NCT06327789

Trunk Control and Disability in Persons With Multiple Sclerosis

Name: Clinical Trial NCT06327789
Creator: Zonguldak Bulent Ecevit University
Keywords: Multiple Sclerosis, clinical trial, Turkey

The Relationship Between Trunk Control and Disability in Persons With Early Relapsing Multiple Sclerosis

Zonguldak Bulent Ecevit University·ClinicalTrials.govCompleted

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Multiple Sclerosis
Study type: Observational

Sponsor & location

Primary sponsor: Zonguldak Bulent Ecevit University
Location: Zonguldak, Turkey

Timeline & enrollment

Phase: N/A
Start date: Dec 21, 2021
End date: Feb 21, 2022
Enrollment: 23 participants

Primary outcome

Expanded Disability Status Scale (EDSS),Trunk Impairment Scale (TIS),Biodex Balance System (BBS) (MedicalSystems, Shirley, NY, USA),Step Length (cm),Stride Length (cm),Step Width (cm),Cadence (steps/min),Velocity (m/s),Step time (s),Stride time (s),Timed 25-Foot Walk Test (T25FW),Nine-Hole Peg Test (9HPT)

Summary

This study aims to investigate the relationship between physical disability and trunk control, balance, and pedobarographic parameters in persons with Relapsing Remitting Multiple Sclerosis (RRMS) who have a low Expanded Disability Status Scale (EDSS) score. Twenty-three RRMS patients with an age range of 18-50 years, EDSS score ≤ 3 were included in this study. The patients' level of disability (EDSS), trunk control )Trunk Impairment Scale - TIS), lower extremity functionality (Timed 25-Foot Walk Test - T25FW), upper extremity functionality (Nine Hole Peg Test- 9HPT), balance (Biodex Balance System) and gait (Zebris® FDM 2) were evaluated.

ICD-10 classifications

Multiple sclerosisProgressive systemic sclerosisSystemic sclerosisSystemic sclerosis, unspecifiedDiffuse sclerosis

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT06327789
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT06327789 through Pure Global AI's free database. This phase not specified trial is sponsored by Zonguldak Bulent Ecevit University and is currently Completed. The study focuses on Multiple Sclerosis. Target enrollment is 23 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.